Dr. Mohamad Adham Salkeni, MD
- Medicare services, 2024
- 308
- Medicare patients, 2024
- 118
- Part D claims, 2024
- 216
- Clinical trials
- 2
- Industry payments
- $13,535
- Practice address
- 8613 Lee Hwy, Fairfax, VA 22031
- Practice phone
- Call (703) 280-5390
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Virginia Cancer Specialists
Fairfax, Virginia
Find Dr. Salkeni's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mohamad Adham Salkeni is a hematologist and oncologist in Fairfax, Virginia
Dr. Salkeni practices at Virginia Cancer Specialists in Fairfax, Virginia.
Dr. Salkeni's NPI, 1265635924, was assigned on June 8, 2007. Dr. Salkeni holds Virginia license 0101275055.
- NPI
- 1265635924NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9234382011
- NPI enumeration date
- June 8, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (703) 280-5390
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mohamad Adham Salkeni practices at Virginia Cancer Specialists in Fairfax, Virginia
Dr. Salkeni's primary practice is Virginia Cancer Specialists, at 8613 Lee Hwy, Fairfax, VA 22031 in Fairfax County. The practice phone is (703) 280-5390.
- Virginia Cancer Specialists8613 Lee Hwy, Fairfax, VA 22031 · Fairfax CountyPhone(703) 280-5390
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mohamad Adham Salkeni is affiliated with 2 sites of care and 1 medical group
Dr. Salkeni's primary practice is Virginia Cancer Specialists in Fairfax, Virginia. The medical group on file is Virginia Cancer Specialists. Dmand AI also links Dr. Salkeni to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Mohamad Adham Salkeni's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salkeni practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Virginia Cancer Specialists | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mohamad Adham Salkeni is one of 297 hematologists and oncologists in Virginia
Hematology and oncology is Dr. Salkeni's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Salkeni's licenses on file in 2 states: Virginia and Missouri.
Specialties and state licenses
- Hematology and oncology, VirginiaPrimary
- Internal medicine, Missouri
Hematologists and oncologists near Dr. Salkeni
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mohamad Adham Salkeni billed Medicare for 308 services in 2024
CMS data shows 308 Medicare services from Dr. Salkeni across 8 procedure codes in 2024, for 118 Medicare patients. Medicare paid $22,901 for them. Every service was in an office.
Dr. Salkeni's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 882024: 15475%
- Tests and treatments
- 2023: 02024: 94
- Lab and pathology
- 2023: 02024: 60
Dr. Salkeni compared with the Virginia median for hematologists and oncologists, 2024
- Dr. Salkeni
- Virginia median
- Medicare services
- 308vs 3,51491% below
- Medicare patients
- 118vs 47475% below
- Part D claims
- 97vs 45279% below
Medians across 275 hematologists and oncologists in Virginia with Dmand AI profiles that report each measure.
Dr. Salkeni's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Salkeni?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Salkeni and other hematologists and oncologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mohamad Adham Salkeni treated 118 Medicare patients in 2024, average age 71
CMS counts 118 Medicare patients who saw Dr. Salkeni in 2024. The largest group is 65 to 74, with 65 patients. 62% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Salkeni's median patient age at 68, with 50% women.
Dr. Salkeni's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Salkeni's Medicare patients by sex, 2024
- Women6858%
- Men5042%
Chronic conditions among Dr. Salkeni's Medicare patients, 2024
- High blood pressure62%
- High cholesterol58%
- Cancer53%
- Diabetes31%
- Arthritis30%
- Anxiety21%
- Ischemic heart disease21%
- Mood disorders21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Salkeni's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women50%
- Men43%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mohamad Adham Salkeni wrote 216 Medicare Part D claims in 2024
In 2024, Dr. Salkeni wrote 216 Medicare Part D claims for 53 patients. 93% of them were for generic drugs. CMS names the drug for 97 of them, across 6 drugs with 11 or more claims each, at $2,872 in total drug cost. In 2022, CMS named 31 claims across 1 drug.
Dr. Salkeni's Part D claims by kind of drug, 2024
- Generic201 claims93%
- Brand-name15 claims7%
Dr. Salkeni's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Salkeni's Part D claims, 2024
- Opioids6%14 of 216 claims
- Antibiotics18%39 of 216 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2022 to 2024
- 2022
- 2024
- Claims for drugs CMS names
- 2022: 312024: 97213%
Drugs named by CMS: 6 in 2024, 1 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Mohamad Adham Salkeni takes part in Medicare
Dr. Salkeni accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mohamad Adham Salkeni has worked on 2 clinical trials
Dmand AI links Dr. Salkeni to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Endometrial Neoplasms, Neoplasm Metastasis and Neoplastic Processes. Open Payments lists research payments to Dr. Salkeni that name 2 trials.
Conditions in Dr. Salkeni's trials
- Endometrial Neoplasms
- Neoplasm Metastasis
- Neoplastic Processes
- Uterine Neoplasms
Investigators on the most trials with Dr. Salkeni
- Rama Balaraman, MD1 shared trial
- Todd Michael Bauer, MD1 shared trial
- David R. Camidge, MD1 shared trial
Recent clinical trials with Dr. Salkeni
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mohamad Adham Salkeni received $13,535 in industry payments from 2016 to 2025
CMS Open Payments shows 36 general payments to Dr. Salkeni from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Daiichi Sankyo Inc. paid the most, $3,525. It also lists 5 research payments totaling $1,427 from 2016 to 2023, naming 2 clinical trials.
General payments to Dr. Salkeni by program year, 2016 to 2025
General payments to Dr. Salkeni by kind, 2016 to 2025
- Consulting fees$9,13067%
- Speaker and faculty fees$2,54019%
- Travel and lodging$1,1248%
- Food and beverage$7145%
- Education$270%
Companies that paid Dr. Salkeni the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Mohamad Adham Salkeni's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mohamad Adham Salkeni
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mohamad Adham Salkeni's NPI number?
Dr. Mohamad Adham Salkeni's NPI number is 1265635924. It was assigned on June 8, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Mohamad Adham Salkeni?
Dr. Mohamad Adham Salkeni is a hematologist and oncologist in Fairfax, Virginia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mohamad Adham Salkeni practice?
Dr. Salkeni practices at 8613 Lee Hwy, Fairfax, VA 22031. Dr. Salkeni's primary practice is Virginia Cancer Specialists in Fairfax, Virginia. Dmand AI also links Dr. Salkeni to 1 group practice or clinic.
What is Dr. Mohamad Adham Salkeni's office phone number?
The practice phone on file for Dr. Salkeni is (703) 280-5390.
What is Dr. Mohamad Adham Salkeni's medical license number?
Dr. Salkeni holds Virginia license 0101275055, one of the licenses on file in 2 states.
Which states has Dr. Mohamad Adham Salkeni been licensed in?
Dmand AI has state licenses on file for Dr. Salkeni in Virginia and Missouri.
What medical group is Dr. Mohamad Adham Salkeni part of?
Dr. Salkeni is linked to Virginia Cancer Specialists.
Does Dr. Mohamad Adham Salkeni accept Medicare?
Yes. CMS data shows Dr. Salkeni billed Medicare for 308 services in 2024, and Dr. Salkeni accepts Medicare assignment.
How many Medicare patients does Dr. Mohamad Adham Salkeni see?
CMS counts 118 Medicare patients who saw Dr. Salkeni in 2024, with an average age of 71.
What services does Dr. Mohamad Adham Salkeni bill to Medicare?
In 2024, Dr. Salkeni's most billed Medicare services were office visit, established patient (99213), infusion or chemotherapy administration (96413) and infusion or chemotherapy administration (96375).
Show 4 more questionsShow fewer questions
What drugs does Dr. Mohamad Adham Salkeni prescribe most?
In 2024 Medicare Part D data, Dr. Salkeni's most prescribed drugs by claims were Doxycycline Hyclate, Metronidazole and Triamcinolone Acetonide.
Has Dr. Mohamad Adham Salkeni received payments from drug or device companies?
CMS Open Payments shows $13,535 in general payments to Dr. Salkeni from 18 companies from 2016 to 2025. The largest total came from Daiichi Sankyo Inc.
How long has Dr. Mohamad Adham Salkeni been practicing?
Dr. Salkeni graduated from medical school in 2005, 21 years ago.
Does Dr. Mohamad Adham Salkeni do research?
Dr. Salkeni has worked on 2 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card